Cytokine release pathway in mononuclear cells stimulated in vitro by dialysis membranes

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 509-514

  Menegatti, Elisa ^a   Rossi, Daniela ^b   Chiara, Marica ^a   Alpa, Mirella ^b   Sena, Luigi M ^a   Roccatello, Dario ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Presidi Ospedalieri ASL4   (Italy)

Author keywords

Dialysis membranes; Interleukin 1 ; Reverse transcription polymerase chain reaction; Tumor necrosis factor ; Western blot

Indexed keywords

ACTIN; COMPLEMENTARY DNA; CUPROPHANE; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; POLYACRYLONITRILE; POLYCLONAL ANTIBODY; POLYSULFONE; POLYVINYLIDENE FLUORIDE; PROTEIN; RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIALYSIS MEMBRANE; ELECTROPHORESIS; GENE EXPRESSION; HOMOGENATE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERNATANT;

GENE EXPRESSION; HUMANS; INTERLEUKIN-1; KIDNEY, ARTIFICIAL; MEMBRANES, ARTIFICIAL; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036979993     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065288     Document Type: Article

References (24)

1. Dinarello CA: Cytokines and biocompatibility. Blood Purif 1990;8:208-213.
2. Caruana RJ, Lobel SA, Leffeli MS, Campbell H, Cheek PL: Tumor necrosis factor, interleukin-1, and beta-2-microglobulin levels in chronic hemodialysis patients. Int J Artif Organs 1990;13:794-798.
3. Shaefer RM, Paczek L, Heidland A: Cytokine production by monocytes during hemodialysis. Nephrol Dial Transplant 1991;6(suppl 2):14-17.
4. Roccatello D, Formica M, Cavalli G, Quattrocchio G, Aimo G, Polloni R, Amprimo MC, Molino A, Martina G, Isidoro C, Mazengo M, Coppo R, Sena LM, Piccoli G: Serum and intracellular detection of cytokines in patients undergoing chronic hemodialysis. Artif Organs 1991;16:131-140.
5. Herbelin A, Urena P, Nguyen AT, Zingrafi J, Descamps-Latscha S: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991;39:954-960.
6. Haran N, Bar-Khayim Y, Frensdorff A, Barnard G: Tumor necrosis factor (TNFα) binding protein: Interference in immunoassay of TNFα. Kidney Int 1991;40:1166-1170.
7. Brockhaus M, Bar-Khayim Y, Gurwicz S, Frensdorff A, Haran N: Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int 1992;42:663-667.
8. Schindler R, Lonnemann G, Shaldon S, Koch K-M, Dinarello CA: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990;37:85-93.
9. Fenton MJ: Review: Transcriptional and post-transcriptional regulation of IL-1 gene expression. Int J Immunopharmacol 1992;14:401-411.
10. Siders WM, Mizel SB: Interleukin-1β secretion. A possible multistep process that is regulated in a cell type-specific manner. J Biol Chem 1995;270:16258-16264.
11. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992;356:768-774.
12. Perregaux DG, Laliberte RE, Gabel CA: Human monocyte interleukin-1β post-translational processing: Evidence of a volume regulated response. J Biol Chem 1996;271:29830-29838.
13. Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, Miller DK, Chapman K, Kostura MJ: The interleukin-1β-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med 1995;182:1447-1459.
14. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramification for the complex physiology of TNF. Cell 1988;53:45-53.
15. Black RA, Durie FH, Otten-Evans C, Miller R, Slack JL, Lynch DH, Castner B, Mohler KM, Gerhart M, Johnson RS, Itoh Y, Okada Y, Nagase H: Relaxed specificity of matrix metalloproteinase (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not a MMP. Biochem Biophys Res Commun 1996;225:400-405.
16. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA: Quantitation of targets for PCR by use of limiting dilutions. BioTechniques 1992;13:444-449.
17. Lonnemann G, Haubitz M, Schindler R: Hemodialysis-associated induction of cytokines. Blood Purif 1990;8:214-222.
18. Schinder R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA: Transcription, not synthesis, of interleukin 1 and tumor necrosis factor by complement. Kidney Int 1990;37:85-90.
19. Schinder R, Linnerweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM: Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993;43:712-721.
20. Menegatti E, Dragonetti A, Nardacchione A, Di Simone D, Francica S, Loduca G, Davit A, Roccatello D, Sena LM, Ronco C: Absence of NF-κB activation in a new device designed for hemoperfusion. J Am Soc Nephrol 2001;12:271A.
21. Goldfeld AE, Doyle C, Maniatis T: Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci USA 1990;87:9769-9773.
22. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis mechanisms for endotoxin resistance. Science 1986;232:977-982.
23. Beutler B, Thompson P, Keyes J, Hagerty K, Crawford D: Assay for a ribonuclease that preferentially hydrolizes mRNAs containing cytokine derived UA-rich instability sequences. Biochem Biophys Res Commun 1988;152:973-976.
24. Suk K, Erickson KL: Differential regulation of tumor necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma. Immunology 1996;87:551-558.